| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.014 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |